The PredART study—published in the New England Journal of Medicine—showed that a four-week course of moderate dose prednisone reduced the risk of TB-IRIS by 30% in HIV-positive patients at high risk.
Primary analysis published in the New England Journal of Medicine shows positive results in clinical trial conducted in tuberculosis endemic regions.
Community stakeholders representing various Khayelitsha-based organisations gathered to consult with CIDRI-Africa’s clinical research team on future tuberculous meningitis research.
Maia will develop novel statistical methods for analysis of complex study data on lung health in Africa.
+27 (0)21 406 6797
Institute of Infectious Disease
and Molecular Medicine
University of Cape Town
Supported by the Wellcome Trust (203135/Z/16/Z)